No retraction, correction or concern found when last checked on Oct 20, 2026.
Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults
Min Kyung Kim, Chul Woo Ahn, Shinae Kang and 3 more
Cardiovascular Diabetology · 2017
Abstract
Background. The triglyceride glucose (TyG) index has been considered a simple surrogate marker of insulin resistance. However, few studies have investigated the relationship between the TyG index and coronary artery calcification (CAC). Thus, we investigated the relationship between the TyG index and CAC in healthy Korean adults.
Methods. In total, 4319 participants who underwent cardiac computed tomography (CT) in a health promotion center were enrolled. Anthropometric profiles and multiple cardiovascular risk factors were measured. The TyG index was calculated as ln [fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2], and the insulin resistance index of homeostasis model assessment (HOMA-IR) was estimated. The CAC was measured using multidetector CT, and CAC presence was defined as an Agatston score of >0.
Results. All subjects were stratified into four groups based on their TyG indices. Significant differences were observed in cardiovascular parameters among the groups, and the prevalence of CAC significantly increased with increasing TyG index. In the logistic regression analysis after adjustment for multiple risk factors, the odds ratio for the prevalence of CAC, when comparing the highest and lowest quartiles of the TyG index was 1.95 (95% CI 1.23–3.11; P for trend = 0.01); the odds ratio for the prevalence of CAC, when comparing the highest and lowest quartiles of HOMA-IR was 1.64 (95% CI 1.12–2.40; P for trend = 0.04). In the receiver operating characteristics analysis, the TyG index was superior to HOMA-IR in predicting CAC.
Conclusion. The TyG index is more independently associated with the presence of coronary artery atherosclerosis than is HOMA-IR in healthy Korean adults.
Electronic supplementary material. The online version of this article (doi:10.1186/s12933-017-0589-4) contains supplementary material, which is available to authorized users.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 20, 2026. Paragraph numbers are ours, so an answer can point at one.
Background
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Coronary artery calcification (CAC), as determined by multidetector computed tomography (CT), is a sensitive measure for detecting the existence of early coronary artery atherosclerosis. Moreover, CAC can have prognostic value for predicting future CVD events.
Insulin resistance (IR) is associated with an increased risk of hyperglycemia, hypertension, and dyslipidemia, which increases the risk of inflammation, altered coagulation, and atherosclerosis. Many studies have demonstrated that IR is one of the most important contributing factors to CVD.
Recently, the triglyceride glucose (TyG) index has been proposed as a reliable and simple surrogate marker of IR. This index is correlated with IR, as assessed by the hyperinsulinemic euglycemic clamp test and the homeostatic model assessment of insulin resistance (HOMA-IR).
Few studies have examined the relationship between the TyG index and CVD events, and their results have been inconsistent. In addition, no study has investigated the relationship between the TyG index and CAC in healthy adults.
Therefore, in the present study, we investigated the relationship between the TyG index and CAC and compared the index with HOMA-IR in healthy Korean adults.
Study population
The study population comprised 5217 Korean subjects who participated in a comprehensive health examination, including cardiac CT, as part of a self-referred health checkup program at the Gangnam Severance Hospital Health Promotion Center from January 2008 to February 2015. The exclusion criteria of this study included patients with elevated triglyceride levels (≥400 mg/dL), any malignancy, acute inflammatory disease, or infectious disease. We also excluded subjects with a history of angina, myocardial infarction or cerebrovascular accidents, hypertension, diabetes, or renal disease. Subjects taking statins or triglyceride-lowering medications (fenofibrate or omega-3) were also excluded. Ultimately, 4319 subjects were enrolled in our final analysis. The study protocol was approved by the Institutional Review Board of Yonsei University College of Medicine.
Clinical characteristics
Height and weight were measured, and body mass index (BMI) was calculated by dividing the weight (kg) by the square of the height (m2). Lifestyle, personal medical history of acute or chronic illness, and medication history were assessed using a standard questionnaire. Systolic and diastolic blood pressures were measured by experienced technicians using an automated blood pressure (BP) monitor (HEM-7080IC; Omron Healthcare, Lake Forest, IL, USA) by placing the arm at heart level after a 5-min rest period. An individual who drinks at least 20 g/day of alcohol was defined as an alcohol drinker. Regular exercise was reported to be positive if the participant performed moderate exercise for more than 30 min at least three times a week. Current smokers were defined as those who reported having smoked cigarettes regularly over the previous 6 months.
Biochemical parameters
Blood samples were obtained from all participants after 12 h of fasting. Fasting plasma glucose (FPG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and triglyceride (TG) levels were determined by enzymatic methods using a Hitachi 7600-120 automated chemistry analyzer (Hitachi, Tokyo, Japan). The low-density lipoprotein cholesterol (LDL-C) level was calculated according to the Friedewald formula. The TyG index was calculated as ln[fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2]. The fasting serum insulin level was determined using chemiluminescence (RIA kit, Daiichi, Japan), and the HOMA-IR index was calculated using the following formula: HOMA-IR = fasting insulin (µU/mL) × fasting glucose (mg/dL)/405.
CAC measurements by multidetector CT
Coronary artery calcification was determined using a multidetector CT scanner (Philips Brilliance 64; Philips Medical System, Best, The Netherlands). A standard prospective ECG-gating protocol with a step-and-shoot technique was used, as previously described. Coronary CT images were analyzed by one of three experienced radiologists, all of whom were blinded to the laboratory and clinical details of the participants at the time of analysis. The quantitative coronary artery calcification score (CACS) was calculated using dedicated software and was expressed as an Agatston score. The presence of CAC was defined as an Agatston score of >0.
Statistical analysis
Continuous variables with a normal distribution were expressed as the mean ± SD, whereas continuous variables with a skewed distribution were presented as median (interquartile range) and were log transformed for analysis. Intergroup comparisons were performed using ANOVA tests. Categorical variables with percentages were compared using Chi square tests. The relationships between CAC and various clinical parameters were examined using Pearson’s correlation. The relationship between the TyG index, HOMA-IR and the presence of CAC was analyzed using logistic regression analysis while controlling for potential confounders. Covariates in the multivariate model, which were chosen for their clinical importance, as well as statistical significance, were age, sex, SBP, BMI, LDL-C, HDL-C, smoking status, alcohol intake, and exercise habits. The area under the curve (AUC) of the receiver operating characteristics (ROC) curve and a 95% confidence interval (CI) were calculated to compare the predictive power of the TyG index and HOMA-IR for CAC. Subgroup analysis was performed after categorizing the subjects according to age, sex, BMI, BP, and LDL-C, and the odds ratio (OR) was compared between the highest and lowest quartiles of the TyG indices. All statistical analyses were performed using the SPSS statistical package, version 20.0 (SPSS, Inc., Chicago, IL, USA) and MedCalc (MedCalc software, Olstead, Belgium). P values of <0.05 were considered statistically significant.
Results
Table 1 shows the clinical and biochemical characteristics of the enrolled subjects. The subjects were stratified into four groups based on their TyG index levels. Significant differences in metabolic parameters were observed among the groups. Age, SBP, DBP, BMI, FPG levels, TC levels, TG levels, LDL-C levels, insulin levels, and HOMA-IR increased and HDL-C levels decreased with an increase in the TyG index. In addition, significant differences in smoking status and alcohol intake were observed among the groups. Exercise habits were not found to be significant according to the TyG index.
In total, 4319 subjects were included. Of these, 3474 did not exhibit coronary artery calcification (CACS = 0), and the remaining 845 exhibited some evidence of CAC (CACS > 0, 19.6%). The prevalence of CAC and the mean CACS significantly increased with an increase in the TyG index (Table 2; Fig. 1).
Pearson correlation analysis was performed to examine the relationship between log-transformed CACS and various clinical parameters (Table 3). CAC showed significant correlations with the TyG index and HOMA-IR, and the correlation between the TyG index and CAC was better than the correlation between HOMA-IR and CAC.
The relationship between the TyG index and the presence of CAC (CACS > 0) was explored by categorizing the TyG index into quartiles using the first quartile as the reference (Table 4). An unadjusted multivariate logistic regression analysis, with I set as a reference, revealed that the TyG indices for II, III and IV had increased OR for the presence of CAC in all subjects (Model 1). After adjusting for confounding variables, including age, sex, SBP, BMI, LDL-C levels, HDL-C levels, smoking status, alcohol, and exercise habit, these relationships remained significant (P for trend < 0.05) (Model 3).
We further evaluated the relationship between the HOMA-IR and the presence of CAC by categorizing HOMA-IR into quartiles using the first quartile as the reference (Table 4). The higher HOMA-IR quartile was significantly associated with the presence of CAC, and these relationships remained significant even after adjusting for confounding variables. After adjustment for multiple risk factors, the OR (95% CI) for having CAC of HOMA-IR in the highest quartile was 1.64 (1.12–2.40), whereas the OR of the TyG index in the highest quartile was 1.95 (1.23–3.11). The AUC (95% CI) of the ROC curve for the TyG index at 0.629 (0.598–0.660) was significantly higher than that of the HOMA-IR at 0.585 (0.554–0.616) (P = 0.016). These results suggest that the TyG index is better than HOMA-IR in predicting CAC.
Adjusted ORs of CAC subgroups were significant regardless of age, sex, BMI, BP, or LDL-C levels. In addition, subjects who were ≥50 years old, male, obese (BMI ≥ 25 kg/m2), had high BP (≥120/80 mmHg), and had high LDL-C (≥130 mg/dL) showed higher ORs compared with those without these risk factors (Additional file 1: Table S1).
Discussion
In this study, we investigated the relationship between the TyG index and CAC in healthy Korean adults and found that the prevalence of CAC was significantly associated with the TyG index, and was independent of conventional cardiovascular risk factors. To the best of our knowledge, this is the first study to investigate the relationship between the TyG index and the presence of early coronary artery atherosclerosis in healthy adults. Furthermore, the TyG index showed higher predictability for CAC than did HOMA-IR.
IR has been proposed as an important cause of several metabolic disease and CVD. The gold standard technique for assessing insulin sensitivity is the hyperinsulinemic euglycemic clamp test, but this method is invasive, laborious, and expensive, and it can only be used for research purposes. Therefore, HOMA-IR was developed as a more convenient method for measuring IR and is widely used in clinical settings. Recently, some studies have shown that the TyG index is correlated with IR, as assessed using the hyperinsulinemic euglycemic clamp test and HOMA-IR, and the TyG index has been considered to be a surrogate marker of IR. In addition, some studies have shown that the predictive value of the TyG index is better than that of HOMA-IR.
Few reports on the relationship between the TyG index and CVD events exist, and these are controversial. In a recent study, Sanchez-Inigo et al. reported that the TyG index might be useful to identify individuals at high risk of a CVD event, whereas another study has shown that the TyG index does not predict CVD events. Furthermore, to date, only two studies have examined the relationship between the TyG index and subclinical atherosclerosis. Irace et al. reported that the TyG index is significantly associated with carotid artery atherosclerosis after adjustment for traditional cardiovascular risk factors. Recently, Lee et al. showed an independent relationship between the TyG index and significant coronary artery stenosis in patients with type 2 diabetes, but the sample size was small (n = 888) and only subjects with type 2 diabetes were included.
In the present study, we demonstrated that the TyG index was independently associated with the presence of CAC in healthy adults. Compared with HOMA-IR, the TyG index is better for predicting subclinical atherosclerosis, and this result corroborates the previous finding that the TyG index showed a stronger association with carotid atherosclerosis than did HOMA-IR.
Although the mechanism underlying the relationship between the TyG index and CAC has not been clarified, it may be linked to IR. Many studies have indicated that IR leads to inflammation, altered coagulation and atherosclerosis. Furthermore, an independent association between IR and CAC has been reported. Both the TyG index and HOMA-IR are well known representative markers of IR, and they are closely related to each other. However, our findings showed that the TyG index was better associated with the presence of coronary artery atherosclerosis than was HOMA-IR, and this result may be explained by the fact that the two indices reflect different aspects of IR. The TyG index reflects IR mainly in the muscle, and HOMA-IR reflects IR mainly in the liver, which may have caused the difference. Peripheral insulin resistance may be a useful marker of coronary artery atherosclerosis.
Our study also had some limitations. First, this was a cross-sectional observational study that could not definitively establish causality. Thus, the precise causal relationship between the TyG index and CAC remains controversial. Second, our study population was relatively small. Third, we did not compare the TyG index using the hyperinsulinemic euglycemic clamp test, the gold standard method for measuring IR. Fourth, we could not record nutritional data. Thus, we could not adjust for nutritional habits, which can affect blood triglyceride levels. Lastly, the participants in the current study were enrolled at one health promotion center, and thus the generalizability of the results may be limited.
Conclusions
The TyG index was significantly associated with the prevalence of CAC, and this relationship remained significant after adjusting for conventional factors. Moreover, the TyG index was more independently associated with the presence of coronary artery atherosclerosis than was HOMA-IR in healthy Korean adults. The TyG index might be a useful marker of atherosclerosis, reflecting cardiovascular risk. Further prospective large-scale studies are required to clarify the mechanisms of this relationship.
References 38
- 1.
Budoff MJ, Achenbach S, Blumenthal RS, Carr JJ, Goldin JG, Greenland P, Guerci AD, Lima JA, Rader DJ, Rubin GD, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on cardiovascular imaging and intervention, council on cardiovascular radiology and intervention, and committee on cardiac imaging, Council on Clinical Cardiology. Circulation. 2006;114(16):1761-1791.
Not in our library10.1161/circulationaha.106.178458
- 2.
Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291(2):210-215.
Not in our library10.1001/jama.291.2.210
- 3.
Pletcher MJ, Tice JA, Pignone M, Browner WS. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med. 2004;164(12):1285-1292.
Not in our library10.1001/archinte.164.12.1285
- 4.
Bressler P, Bailey SR, Matsuda M, DeFronzo RA. Insulin resistance and coronary artery disease. Diabetologia. 1996;39(11):1345-1350.
Not in our library10.1007/s001250050581
- 5.
Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio heart study. Diabetes Care. 2002;25(7):1177-1184.
Not in our library10.2337/diacare.25.7.1177
- 6.
Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study. Diabetes Care. 2007;30(2):318-324.
Not in our library10.2337/dc06-0919
- 7.
Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299-304.
Not in our library10.1089/met.2008.0034
- 8.
Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zavala MG, Hernandez-Gonzalez SO, Jacques-Camarena O, Rodriguez-Moran M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347-3351.
Not in our library10.1210/jc.2010-0288
- 9.
- 10.
Vasques AC, Novaes FS, de Oliveira Mda S, Souza JR, Yamanaka A, Pareja JC, Tambascia MA, Saad MJ, Geloneze B. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98-e100.
Not in our library10.1016/j.diabres.2011.05.030
- 11.
Lee SH, Han K, Yang HK, Kim MK, Yoon KH, Kwon HS, Park YM. Identifying subgroups of obesity using the product of triglycerides and glucose: the Korea National Health and Nutrition Examination Survey, 2008–2010. Clin Endocrinol (Oxf). 2015;82(2):213-220.
Not in our library10.1111/cen.12502
- 12.
Vega GL, Barlow CE, Grundy SM, Leonard D, DeFina LF. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. J Investig Med. 2014;62(2):345-349.
Not in our library10.2310/jim.0000000000000044
- 13.
Sanchez-Inigo L, Navarro-Gonzalez D, Fernandez-Montero A, Pastrana-Delgado J, Martinez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189-197.
Not in our library10.1111/eci.12583
- 14.
Kim S, Kyung C, Park JS, Lee SP, Kim HK, Ahn CW, Kim KR, Kang S. Normal-weight obesity is associated with increased risk of subclinical atherosclerosis. Cardiovasc Diabetol. 2015;14:58.
Not in our library10.1186/s12933-015-0220-5
- 15.
Jung DH, Lee HR, Lee YJ, Kim JK, Park BJ, Shim JY. The association between coronary artery calcification and mean platelet volume in the general population. Platelets. 2011;22(8):567-571.
Not in our library10.3109/09537104.2011.580397
- 16.
Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M. Prevalence of insulin resistance in metabolic disorders: the Bruneck study. Diabetes. 1998;47(10):1643-1649.
Not in our library10.2337/diabetes.47.10.1643
- 17.
Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1997;82(11):3619-3624.
Not in our library10.1210/jcem.82.11.4351
- 18.
Bonora E, Targher G, Alberiche M, Bonadonna RC, Zenere MB, Saggiani F, Muggeo M. Intracellular partition of plasma glucose disposal in hypertensive and normotensive subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2001;86(5):2073-2079.
Not in our library10.1210/jcem.86.5.7455
- 19.
DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214-E223.
Not in our library10.1152/ajpendo.1979.237.3.e214
- 20.
Cutfield WS, Jefferies CA, Jackson WE, Robinson EM, Hofman PL. Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepubertal children. Pediatr Diabetes. 2003;4(3):119-125.
Not in our library10.1034/j.1399-5448.2003.t01-1-00022.x
- 21.
Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med. 2002;19(7):527-534.
Not in our library10.1046/j.1464-5491.2002.00745.x
- 22.
Guerrero-Romero F, Villalobos-Molina R, Jimenez-Flores JR, Simental-Mendia LE, Mendez-Cruz R, Murguia-Romero M, Rodriguez-Moran M. Fasting triglycerides and glucose index as a diagnostic test for insulin resistance in young adults. Arch Med Res. 2016;47(5):382-387.
Not in our library10.1016/j.arcmed.2016.08.012
- 23.
- 24.
- 25.
Irace C, Carallo C, Scavelli FB, De Franceschi MS, Esposito T, Tripolino C, Gnasso A. Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract. 2013;67(7):665-672.
Not in our library10.1111/ijcp.12124
- 26.
- 27.
Trovati M, Anfossi G, Cavalot F, Massucco P, Mularoni E, Emanuelli G. Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo. Diabetes. 1988;37(6):780-786.
Not in our library10.2337/diab.37.6.780
- 28.
Kahn AM, Allen JC, Seidel CL, Zhang S. Insulin inhibits migration of vascular smooth muscle cells with inducible nitric oxide synthase. Hypertension. 2000;35(1 Pt 2):303-306.
Not in our library10.1161/01.hyp.35.1.303
- 29.
Defronzo RA. Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773-795.
Not in our library10.2337/db09-9028
- 30.
Hedblad B, Nilsson P, Engstrom G, Berglund G, Janzon L. Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med. 2002;19(6):470-475.
Not in our library10.1046/j.1464-5491.2002.00719.x
- 31.
Meigs JB, Larson MG, D’Agostino RB, Levy D, Clouse ME, Nathan DM, Wilson PW, O’Donnell CJ. Coronary artery calcification in type 2 diabetes and insulin resistance: the Framingham offspring study. Diabetes Care. 2002;25(8):1313-1319.
Not in our library10.2337/diacare.25.8.1313
- 32.
Yamazoe M, Hisamatsu T, Miura K, Kadowaki S, Zaid M, Kadota A, Torii S, Miyazawa I, Fujiyoshi A, Arima H, et al. Relationship of insulin resistance to prevalence and progression of coronary artery calcification beyond metabolic syndrome components: Shiga epidemiological study of subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 2016;36(8):1703-1708.
Not in our library10.1161/atvbaha.116.307612
- 33.
Kim LK, Yoon JW, Lee DH, Kim KM, Choi SH, Park KS, Jang HC, Kim MK, Park HE, Choi SY, et al. Impact of metabolic syndrome on the progression of coronary calcium and of coronary artery disease assessed by repeated cardiac computed tomography scans. Cardiovasc Diabetol. 2016;15:92.
Not in our library10.1186/s12933-016-0404-7
- 34.
Han T, Cheng Y, Tian S, Wang L, Liang X, Duan W, Na L, Sun C. Changes in triglycerides and high-density lipoprotein cholesterol may precede peripheral insulin resistance, with 2-h insulin partially mediating this unidirectional relationship: a prospective cohort study. Cardiovasc Diabetol. 2016;15(1):154.
Not in our library10.1186/s12933-016-0469-3
- 35.
Kelley DE, Goodpaster BH. Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care. 2001;24(5):933-941.
Not in our library10.2337/diacare.24.5.933
- 36.
Riboldi BP, Luft VC, de Castilhos CD, de Cardoso LO, Schmidt MI, Barreto SM, de Sander MF, Alvim SM, Duncan BB. Glucose and triglyceride excursions following a standardized meal in individuals with diabetes: ELSA-Brasil study. Cardiovasc Diabetol. 2015;14:21.
Not in our library10.1186/s12933-015-0181-8
- 37.
Tripathy D, Almgren P, Tuomi T, Groop L. Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity. Diabetes Care. 2004;27(9):2204-2210.
Not in our library10.2337/diacare.27.9.2204
- 38.
Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23(1):57-63.
Not in our library10.2337/diacare.23.1.57
Cited by papers we hold 16
- Association between the triglyceride glucose (TyG) index and the risk of acute kidney injury in critically ill patients with heart failure: analysis of the MIMIC-IV database · 2023No notice
- Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis · 2023No notice
- Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis · 2022No notice
- Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations · 2022No notice
- Prognostic value of triglyceride glucose (TyG) index in patients with acute decompensated heart failure · 2022No notice
- Association between triglyceride-glucose index and risk of arterial stiffness: a cohort study · 2021No notice
- The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study · 2020No notice
- Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline · 2020No notice
- The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome · 2019No notice
- Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study · 2019No notice
- Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care · 2019No notice
- High triglyceride–glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention · 2019No notice
- Relationship of insulin resistance estimated by triglyceride glucose index to arterial stiffness · 2018Not checked
- Association between insulin resistance and the development of cardiovascular disease · 2018No notice
- Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance · 2018No notice
- Association between triglyceride glucose index and arterial stiffness in Korean adults · 2018No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.